MLA medical australia limited

mla acquires medivet for 10m, page-6

  1. 8,256 Posts.
    Yep

    At $4.5m Market Cap and absolute peanuts SP, this is strategically very good.

    Medivet is turning over revenue and is profitable and is the leader in this stem cell space for animals.

    Medical Australia had involvement in Medivet in different parts of the chain and this deal finally shores things up so that they can guarantee a return at the most lucrative point - retail.

    Finally, over time, the profit will cover more than just wages and admin costs.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.